Gerrit Dispersyn Insider Trading $PHIO Phio Pharmaceuticals Corp.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gerrit Dispersyn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gerrit Dispersyn. Gerrit Dispersyn is Chief Development Officer in RXi Pharmaceuticals Corp ($RXII) and President & CEO in Phio Pharmaceuticals Corp. ($RXII) and President & COO in Phio Pharmaceuticals Corp. ($RXII).
Gerrit Dispersyn in Phio Pharmaceuticals Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gerrit Dispersyn: President & CEO, President & COO, Chief Development Officer
Holdings: 89,281 shares
Current Value: $57,140
Latest Transaction: Mar 05 2021
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Gerrit Dispersyn in Phio Pharmaceuticals Corp.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2021 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Buy | P | 2.56 | 1,953 | 5,000 | 89,281 | 87.3 K to 89.3 K (+2.24 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Buy | P | 3.03 | 2,500 | 7,575 | 87,328 | 84.8 K to 87.3 K (+2.95 %) |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Grant | A | 0.00 | 68,450 | 0 | 84,828 | 16.4 K to 84.8 K (+417.94 %) |
| Aug 19 2020 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Buy | P | 2.50 | 2,000 | 5,000 | 16,377 | 14.4 K to 16.4 K (+13.91 %) |
| Mar 03 2020 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Payment of Exercise | F | 2.93 | 673 | 1,972 | 14,628 | 15.3 K to 14.6 K (-4.40 %) |
| Nov 20 2019 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Grant | A | 0.10 | 350,000 | 35,000 | 827,817 | 477.8 K to 827.8 K (+73.25 %) |
| Aug 02 2019 | PHIO | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Payment of Exercise | F | 0.40 | 1,236 | 498 | 477,817 | 479.1 K to 477.8 K (-0.26 %) |
| Mar 05 2019 | RXII | Phio Pharmaceutica ... | Dispersyn Gerrit | President & CEO | Grant | A | 0.00 | 407,703 | 0 | 479,053 | 71.4 K to 479.1 K (+571.41 %) |
| Feb 15 2019 | RXII | Phio Pharmaceutica ... | Dispersyn Gerrit | President & COO | Grant | A | 0.00 | 55,000 | 0 | 71,350 | 16.4 K to 71.4 K (+336.39 %) |
| Aug 03 2018 | RXII | RXi Pharmaceutical ... | Dispersyn Gerrit | Chief Development O ... | Option Exercise | A | 1.79 | 16,000 | 28,640 | 16,000 | |
| Aug 03 2018 | RXII | RXi Pharmaceutical ... | Dispersyn Gerrit | Chief Development O ... | Grant | A | 0.00 | 16,000 | 0 | 16,350 | 350 to 16.4 K (+4,571.43 %) |
| Jun 26 2017 | RXII | RXi Pharmaceutical ... | Dispersyn Gerrit | Chief Development O ... | Buy | P | 0.62 | 3,500 | 2,170 | 3,500 | 0 to 3.5 K |
| Apr 26 2017 | RXII | RXi Pharmaceutical ... | Dispersyn Gerrit | Chief Development O ... | Option Exercise | A | 0.65 | 95,000 | 61,750 | 95,000 |
Page: 1